Results from two Pradaxa trials to be presented at WSC

Results from Pradaxa ® RE-SPECT ESUS® and RE-SPECT CVT® trials to be presented at the 11th World Stroke CongressData from key trials will aid in increasing scientific understanding of ESUS and CVTRESPECT-ESUS is first randomised trial to investigate clinical profile of Pradaxa ® vs ASA

Source: Boehringer Ingelheim Corporate News - October 12, 2018 Category: Research Source Type: news